These dose-response profiles indicate that curcumin induces cell death in breast cancer cells, with triple negative breast cancer cells showing a trend toward increased sensitivity versus ER-positive/HER2-over-expressing cells. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.